Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer
José Baselga*, Patricia Gómez, Richard Greil, Sofia Braga, Miguel A. Climent, Andrew M. Wardley, Bella Kaufman, Salomon M. Stemmer, António Pego, Arlene Chan, Jean Charles Goeminne, Marie Pascale Graas, M. John Kennedy, Eva Maria Ciruelos Gil, Andreas Schneeweiss, Angela Zubel, Jutta Groos, Helena Melezínkova, Ahmad Awada
Research output: Contribution to journal › Article › peer-review
303Scopus
citations
Fingerprint
Dive into the research topics of 'Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer'. Together they form a unique fingerprint.